Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

32 trials with published results (12%)

Research Maturity

159 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.3%

22 terminated out of 264 trials

Success Rate

87.8%

+1.3% vs benchmark

Late-Stage Pipeline

17%

45 trials in Phase 3/4

Results Transparency

20%

32 of 159 completed with results

Key Signals

32 with results88% success22 terminated

Data Visualizations

Phase Distribution

184Total
Not Applicable (99)
Early P 1 (2)
P 1 (15)
P 2 (23)
P 3 (22)
P 4 (23)

Trial Status

Completed159
Unknown40
Terminated22
Withdrawn15
Recruiting13
Active Not Recruiting6

Trial Success Rate

87.8%

Benchmark: 86.6%

Based on 159 completed trials

Clinical Trials (264)

Showing 20 of 20 trials
NCT04540380Phase 1Active Not RecruitingPrimary

Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH

NCT06054035Phase 4Recruiting

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

NCT07679568Not Yet Recruiting

Analysis of Continuous Kidney Replacement Therapy (CKRT) Treatments With multiFlux Hemofilters Using Regional Citrate Anticoagulation (RCA) or Systemic Heparin Anticoagulation

NCT06603324Not ApplicableRecruitingPrimary

Analysis of Paediatric Treatments With multiFiltratePRO

NCT01366144Phase 1Active Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

NCT06390592Not ApplicableNot Yet RecruitingPrimary

Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony

NCT07058909Not ApplicableCompletedPrimary

Premarket Clinical Safety Assessment of the ELISIO™-HX

NCT05282732CompletedPrimary

Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients

NCT02644941Phase 3CompletedPrimary

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis

NCT06203977Phase 2Completed

Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)

NCT00561483Completed

Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure

NCT06478524Not ApplicableCompletedPrimary

Music Intervention for Dialysis Patients

NCT07618858Not ApplicableNot Yet Recruiting

Comparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration

NCT03242343Not ApplicableCompleted

VasQ External Support for Arteriovenous Fistula

NCT05662267Completed

Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.

NCT06142396Early Phase 1Recruiting

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

NCT04141358Completed

Advanced Ultrasound Applications for Predicting AVF Outcomes

NCT06001827Not ApplicableRecruiting

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

NCT05443321Not ApplicableEnrolling By Invitation

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

NCT07293936Not ApplicableRecruiting

Post-Filter Hematocrit

Scroll to load more

Research Network

Activity Timeline